CO2 Energy Transition 3Q 2026: Net income $44.01K — 10-Q Summary

CO2 Energy Transition reported a net income of $44.01K for 3Q 2026, an 89.9% decline YoY due to lower interest on investments, higher costs, and lower taxes. The company had no operating revenue and continues seeking a business combination. Share redemptions left 1.03M public shares outstanding, according to the 10-Q filing.

Original reporting
Published Nov 13, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CO2 Energy Transition 3Q 2026: Net income $44.01K — 10-Q Summary — source image
Decision brief

The 30-second read

$NOEMBearishLow
01

Why it matters

The filing underscores the SPAC's struggle to find a partner, with heavy shareholder redemptions signaling waning confidence.

02

Market read

Micro‑cap SPAC news with limited broader market relevance; primarily of interest to niche investors.

03

What to watch

Potential hidden value in the trust account assets and any undisclosed partnership talks.

Relevance 5/10Novelty 5/10Timing: post‑market today

Background

CO2 Energy Transition Corp. filed its Q3 2026 10‑Q, showing a steep earnings decline and ongoing SPAC combination efforts.

Company-level read

Ticker impact

$NOEMBearishMedium confidence
Context

10-Q reports net income of $44.01K, a sharp YoY decline and ongoing business combination status.

Expected impact

likely downward pressure as market prices in weak earnings and high redemption activity

Evidence & confidence

The filing reveals a significant net‑income drop and 85% of public shares redeemed, indicating reduced investor confidence.

Market effects

Limited impact; reflects challenges for SPACs seeking combinations in the energy transition space.

Minimal; primarily affects US micro‑cap investors.

Low; no broader market or sector ripple effects.

Counterpoint

If the company secures a compelling combination soon, the current discount may present a speculative upside.

Key entities

  • CO2 Energy Transition Corp.

    SPAC focused on energy transition investments.

Related articles

$SBCHigh

Why SBC Medical Stock Skyrocketed on Friday

SBC Medical Group (NASDAQ:SBC) shares rose 37% after reporting Q3 revenue of $59M, up 35% YoY, and announcing an AI partnership with NeuroBrain Dynamics. The company added 36 clinics, increasing total locations to 293, and saw a 9% rise in patient visits. Operating income surged 66% to $26M, with a 45% operating margin.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.